Subsidence of Short Stem THA With DORR Type C
Short Stem Total Hip Arthroplasty in Patients With DORR Type C Femur Configuration: Measured Subsidence
1 other identifier
observational
108
1 country
1
Brief Summary
Total hip arthroplasty (THA) is a widely accepted procedure for the treatment of end-stage hip osteoarthritis. Neck preserving short stems have gained popularity in recent years, as they aim to preserve proximal femoral bone stock and enable a more physiological load transfer. However, the use of these stems in patients with specific femoral deformities, such as DORR Type C femurs, can present unique challenges. DORR Type C femurs are characterized by decreased cortical bone thickness and increased medullary canal width, which can impact the fit and stability of the femoral stem component. Short stem total hip arthroplasty has emerged as a potential solution for these patients, as it aims to preserve proximal femoral bone stock and improve load transfer to the surrounding bone. This study seeks to investigate the measured subsidence of short stem total hip arthroplasty in patients with DORR Type C femur configuration and the clinical outcomes associated with this approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedFirst Submitted
Initial submission to the registry
December 1, 2024
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedMarch 12, 2026
March 1, 2026
1.6 years
December 1, 2024
March 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Stem Subsidence
Subsidence of the femoral stem, measured in mm
2 years
Secondary Outcomes (3)
HHS
2 years
OHS
2 years
SF-12
2 years
Study Arms (1)
Dorr C Hip
Patients who received short stem THA with a Dorr C configuration of the femur
Interventions
Total Hip Arthroplasty using a collarless, triple-tapered cementless short stem (Optimys, produced by Mathys).
Eligibility Criteria
108 patients were eligible, of which 55 underwent routine follow-ups. Complete data was available from 44 patients. 22 patients each were male and female. Mean age at surgery was 68.3 years. Mean BMI was 27.9 kg/m2
You may qualify if:
- THA using Optimys short stem from 1.1.2018 bis 31.12.2020 in the institution.
- Typ C Femur according to Dorr
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ordensklinikum Linz Barmherzige Schwestern
Linz, 4010, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2024
First Posted
January 10, 2025
Study Start
January 1, 2023
Primary Completion
July 31, 2024
Study Completion
March 31, 2025
Last Updated
March 12, 2026
Record last verified: 2026-03